{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-015124","form_type":"8-K","ticker":"IMNN","cik":"0000749647","company_name":"Imunon, Inc.","filed_at":"2025-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.151065+00:00","generated_at":"2026-05-19T09:34:27.757601+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Imunon terminates interim CFO Gaiero, appoints Kimberly Graper as interim CFO effective June 13","bullets":["Terminated consulting agreement with Monomoy Advisors and David Gaiero as interim CFO, effective June 13, 2025.","Kimberly Graper appointed interim CFO, also serving as principal financial and accounting officer.","Graper has been VP of Finance and Corporate Controller at Imunon since October 2022.","Her annual salary is $244,800 with a target bonus of 30% of base salary.","Graper holds a BS in Accounting from Clemson and a JD from Seton Hall; CPA licensed in New Jersey."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-015124","json":"https://secwatch.observer/filing/0001641172-25-015124.json","markdown":"https://secwatch.observer/filing/0001641172-25-015124.md","text":"https://secwatch.observer/filing/0001641172-25-015124.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/749647/000164117225015124/0001641172-25-015124-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/749647/000164117225015124/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T09:34:27.757601+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3660866ff2","claim":"David Gaiero was terminated as interim Chief Financial Officer at Imunon, Inc..","evidence_excerpt":"On June 13, 2025, Imunon, Inc. (the “Company”) terminated the consulting agreement (as amended, the “Agreement”), dated April 15, 2024, by and between the Company and Monomoy Advisors, LLC, a financial advisory services firm (“Monomoy”), as well as David Gaiero’s service pursuant to the Agreement as the Company’s interim Chief Financial Officer (a position he has held since June of 2024), in each case effective June 13, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/749647/000164117225015124/0001641172-25-015124-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"interim Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"6003df3fab","claim":"Kimberly Graper was appointed as interim Chief Financial Officer at Imunon, Inc..","evidence_excerpt":"As a result of the termination of the Agreement and Mr. Gaiero’s related service, effective June 13, 2025, the Company appointed Kimberly Graper to serve as the Company’s interim Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/749647/000164117225015124/0001641172-25-015124-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"interim Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}